top of page
TheVitaDoc™

Probiotics for a healthy biome. Including Saccharomyces Boulardii. And its role in neutralizing C Diff toxins. Search augmentation via OpenEvidence.com



Excerpt from above:

Saccharomyces boulardii (S. boulardii) is a probiotic yeast with several key benefits for intestinal health, particularly in the context of Clostridioides difficile (C. difficile) infection (CDI).


Key Benefits:

1. Inhibition of Pathogens: S. boulardii produces proteases that inactivate C. difficile toxins A and B, reducing their pathogenicity.


2. Immune Modulation: It enhances the immune response by increasing the production of secretory IgA and modulating cytokine production.


3. Gut Barrier Function: S. boulardii helps maintain and restore the integrity of the intestinal barrier, reducing permeability and preventing translocation of pathogens.


Evidence for CDI Recurrence Prevention:

Several studies support the use of S. boulardii in preventing recurrent CDI:


• A multicenter double-blind RCT demonstrated a significant reduction in CDI recurrence when S. boulardii was used alongside metronidazole or vancomycin in patients with a history of recurrent CDI (RR 0.43, 34.6% with S. boulardii vs. 64.7% with placebo).


• A follow-up study showed benefits in a subgroup treated with high-dose vancomycin and S. boulardii, with a recurrence rate of 16.7% compared to 50% with placebo.


• A controlled prospective intervention study indicated that S. boulardii significantly reduced CDI rates in hospitalized patients receiving antibiotics (OR = 0.06, 95% CI 0.02-0.16).


Dosage:

The typical dosage used in clinical studies is 1 g/day, which corresponds to approximately 5 billion CFU, administered in divided doses.


Guideline Recommendations:

The American College of Gastroenterology (ACG) guidelines acknowledge the potential role of S. boulardii in preventing recurrent CDI, particularly in patients with a history of recurrence.

In summary, S. boulardii has demonstrated efficacy in reducing the recurrence of CDI, particularly when used in conjunction with standard antibiotic therapy in patients with a history of recurrent infections.


Feel free to share this post with friends and family. Thank you for taking the time to read this post

10 views

Recent Posts

See All

تعليقات


bottom of page